Search
Parkinson's Disease Clinical Trials in Norfolk, VA
A listing of 2 Parkinson's Disease clinical trials in Norfolk, VA actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1 - 2 of 2
The city of Norfolk, Virginia, currently has 2 active clinical trials seeking participants for Parkinson's Disease research studies.
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Featured Trial
Major Depressive Disorder Clinical Study
Recruiting
Is depression weighing you down? Local major depressive disorder clinical studies are now enrolling participants in the area. Participating in research studies helps contribute to the advancement of future medicine and treatment options. There is no obligation to take part and health insurance is not required.
Conditions:
Major Depressive Disorder
Major Depression
Major Depressive Episode
Major Depressive Disorder (MDD)
Major Depressive Disorders
Featured Trial
Hyperacusis Activities Treatment-Online Study
Recruiting
Are you experiencing hyperacusis? If so, we are recruiting adults with hyperacusis to complete a clinical trial supported by the National Institutes of Health. The study involves participating in a remote counseling program and sound therapy trial for hyperacusis, Hyperacusis Activities Treatment-Online.
Conditions:
Hyperacusis
Tinnitus
Hearing Loss
Featured Trial
Irritability Associated with Autism (Children and Adolescents) Study
Recruiting
Sign up for a clinical trial today and contribute to the advancement of medical research, paving the way for innovative treatments. Receive financial compensation for your participation and benefit from complimentary medical care.
Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy
Recruiting
This study is designed to evaluate the safety and efficacy of dipraglurant in PD patients with dyskinesia (randomized 1:1 to receive active or placebo) for 12 weeks (1 week at 150 mg per day and 11 weeks at 300 mg per day). The primary efficacy assessment will be based on the Unified Dyskinesia Rating Scale (UDysRS). Patients who complete the 12-week blinded treatment period may have the option to roll into an open-label safety extension study for an additional 12-month treatment period.
Gender:
All
Ages:
Between 30 years and 85 years
Trial Updated:
05/18/2022
Locations: Meridian Clinical Research (Norfolk, Virginia), Norfolk, Virginia
Conditions: Parkinson Disease, Dyskinesia, Drug-Induced, Dyskinesias
Self-Reports of Executive Functions in Persons With Parkinson's Disease and Their Significant Others
Recruiting
The investigators are conducting a study to compare the self-reports of executive functions (that is to say, what role cognitive processes such as working memory and attention) in persons with Parkinson's Disease to the reports of executive functions completed by their significant others.
To conduct this study, the investigators need the participation of persons who are diagnosed with Parkinson's Disease and their significant others.
Gender:
All
Ages:
Between 30 years and 79 years
Trial Updated:
06/15/2021
Locations: Old Dominion University, Norfolk, Virginia
Conditions: Parkinsonism or Parkinson's Disease Nos
1 - 2 of 2